Correction: Pandey et al. ROR1 Potentiates FGFR Signaling in Basal-Like Breast Cancer. Cancers 2019, 11, 718

Cancers (Basel). 2022 Sep 19;14(18):4529. doi: 10.3390/cancers14184529.

Gaurav Pandey¹, Nicholas Borcherding^{1

2

3}, Ryan Kolb⁴, Paige Kluz¹, Wei Li⁴, Sonia Sugg⁵, Jun Zhang⁶, Dazhi A Lai⁷, Weizhou Zhang⁴

¹ Department of Pathology, College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
² Cancer Biology Graduate Program, College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
³ Medical Scientist Training Program, College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
⁴ Department of Pathology, Immunology, and Laboratory Medicine, University of Florida, Gainesville, FL 32610, USA.
⁵ Department of Surgery, College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
⁶ Division of Hematology, Oncology and Blood & Marrow Transplantation, Department of Internal Medicine, College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
⁷ Speed Biosystems, Gaithersburg, MD 20878, USA.

Abstract

In the original publication [...].